APA (7th ed.) Citation

J, L., M, F., C, C., G, B., F, B., AS, B., . . . P, M. (2021). Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients. Current HIV research, 19(1), 84. https://doi.org/10.2174/1570162X18666200824101838

Chicago Style (17th ed.) Citation

J, Lagoutte-Renosi, et al. "Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients." Current HIV Research 19, no. 1 (2021): 84. https://doi.org/10.2174/1570162X18666200824101838.

MLA (9th ed.) Citation

J, Lagoutte-Renosi, et al. "Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients." Current HIV Research, vol. 19, no. 1, 2021, p. 84, https://doi.org/10.2174/1570162X18666200824101838.